California-based Biolinq, a health technology company developing precision multi-analyte wearable biosensors for metabolic health, announced it scored $58 million in financing.
Alpha Wave Ventures led the round, with participation from Niterra’s corporate venture capital fund, which is jointly operated with Pegasus Tech Ventures.
Existing investors, including AXA IM Alts, Senvest Management,...
